CJM-112
Product Specifications
Target
Interleukin
Related Pathways
Immunology/Inflammation
Bioactivity
CJM-112 is a humanized monoclonal antibody inhibitor that targets interleukin-17A (IL-17A) . It holds potential for research in inflammatory diseases, such as hidradenitis suppurativa, which involve abnormalities in the IL-17A-related pathway.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1258824-01 0.02 mg (E-Coli)
Recombinant Thermotoga petrophila Nucleoside-triphosphatase THEP1 (Tpet_0887)
Ask
View Details 
MBS1258824-02 0.1 mg (E-Coli)
Recombinant Thermotoga petrophila Nucleoside-triphosphatase THEP1 (Tpet_0887)
Ask
View Details 
MBS1258824-03 0.02 mg (Yeast)
Recombinant Thermotoga petrophila Nucleoside-triphosphatase THEP1 (Tpet_0887)
Ask
View Details 
MBS1258824-04 0.1 mg (Yeast)
Recombinant Thermotoga petrophila Nucleoside-triphosphatase THEP1 (Tpet_0887)
Ask
View Details MBS1258824-05 0.02 mg (Baculovirus)
Recombinant Thermotoga petrophila Nucleoside-triphosphatase THEP1 (Tpet_0887)
Ask
View Details MBS1258824-06 0.02 mg (Mammalian-Cell)
Recombinant Thermotoga petrophila Nucleoside-triphosphatase THEP1 (Tpet_0887)
Ask
View Details